Kim D., Kim R. G., Kim H. S., Kim J. M., Jun S. C., Lee B., Jo H. J., Rosa-Neto P., Lee M. C., Kim H. I. (2014). Longitudinal changes in resting-state brain activity in a capsular infarct model, J Cereb Blood Flow Metab. Find out more.

Kim H. S., Kim D., Kim R. G., Kim J. M., Chung E., Rosa-Neto P., Lee M. C., Kim H. I. (2014). A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study, J Cereb Blood Flow Metab, 34(4), 683-9. Find out more.

Lataster J., Collip D., Ceccarini J., Hernaus D., Haas D., Booij L., van Os J., Pruessner J., Van Laere K., Myin-Germeys I. (2014). Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex, Schizophr Bull, 40(1), 66-77. Find out more.

Ledoux A. A., Boyer P., Phillips J. L., Labelle A., Smith A., Bohbot V. (2014). Structural hippocampal anomalies in a schizophrenia population correlate with navigation performance on a wayfinding task, Front Behav Neurosci, 8, 88. Find out more.

Leduc V., De Beaumont L., Theroux L., Dea D., Aisen P., Petersen R. C., Dufour R., Poirier J. (2014). HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study, Mol Psychiatry. Find out more.

Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. Find out more.

Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. Find out more.

Liu S. Y., Wrosch C., Miller G. E., Pruessner J. (2014). Self-esteem change and diurnal cortisol secretion in older adulthood, Psychoneuroendocrinology, 41, 111-20. Find out more.

Liu Z., Zhou J., Li Y., Hu F., Lu Y., Ma M., Feng Q., Zhang J. E., Wang D., Zeng J., Bao J., Kim J. Y., Chen Z. F., El Mestikawy S., Luo M. (2014). Dorsal raphe neurons signal reward through 5-HT and glutamate, Neuron, 81(6), 1360-74. Find out more.

Lopez J. P., Lim R., Cruceanu C., Crapper L., Fasano C., Labonte B., Maussion G., Yang J. P., Yerko V., Vigneault E., El Mestikawy S., Mechawar N., Pavlidis P., Turecki G. (2014). miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment, Nat Med, 20(7), 764-8. Find out more.

Lucassen P. J., Pruessner J., Sousa N., Almeida O. F., Van Dam A. M., Rajkowska G., Swaab D. F., Czeh B. (2014). Neuropathology of stress, Acta Neuropathol, 127(1), 109-35. Find out more.

Luck T., Riedel-Heller S. G., Luppa M., Wiese B., Bachmann C., Jessen F., Bickel H., Weyerer S., Pentzek M., Konig H. H., Prokein J., Eisele M., Wagner M., Mosch E., Werle J., Fuchs A., Brettschneider C., Scherer M., Breitner J., Maier W. (2014). A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study, Acta Psychiatr Scand. Find out more.

Ma W., Quirion R. (2014). Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions, Expert Opin Ther Targets, 18(4), 459-72. Find out more.

Magon S., Chakravarty M., Amann M., Weier K., Naegelin Y., Andelova M., Radue E. W., Stippich C., Lerch J. P., Kappos L., Sprenger T. (2014). Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability, Hum Brain Mapp, 35(8), 4193-203. Find out more.

Magon S., Gaetano L., Chakravarty M., Lerch J. P., Naegelin Y., Stippich C., Kappos L., Radue E. W., Sprenger T. (2014). White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study, BMC Neurosci, 15, 106. Find out more.

Maillet D., Rajah M. (2014). Dissociable roles of default-mode regions during episodic encoding, NeuroImage, 89, 244-55. Find out more.

Maillet D., Rajah M. (2014). Age-related differences in brain activity in the subsequent memory paradigm: a meta-analysis, Neurosci Biobehav Rev, 45, 246-57. Find out more.

Menard C., Herzog H., Schwarzer C., Quirion R. (2014). Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits, Neurodegener Dis, 13(2-3), 82-5. Find out more.

Menard C., Quirion R., Bouchard S., Ferland G., Gaudreau P. (2014). Glutamatergic signaling and low prodynorphin expression are associated with intact memory and reduced anxiety in rat models of healthy aging, Front Aging Neurosci, 6, 81. Find out more.

Milella M. S., Marengo L., Larcher K., Fotros A., Dagher A., Rosa-Neto P., Benkelfat C., Leyton M. (2014). Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study, NeuroImage, 98, 195-202. Find out more.